4/20
08:03 am
artl
Artelo Announces Peer-Reviewed Publication Supporting its FABP5 Inhibitor ART26.12 as a Novel Pain Treatment with a Potentially First-in-Class Profile [Yahoo! Finance]
High
Report
Artelo Announces Peer-Reviewed Publication Supporting its FABP5 Inhibitor ART26.12 as a Novel Pain Treatment with a Potentially First-in-Class Profile [Yahoo! Finance]
4/20
07:50 am
artl
Artelo Announces Peer-Reviewed Publication Supporting its FABP5 Inhibitor ART26.12 as a Novel Pain Treatment with a Potentially First-in-Class Profile
High
Report
Artelo Announces Peer-Reviewed Publication Supporting its FABP5 Inhibitor ART26.12 as a Novel Pain Treatment with a Potentially First-in-Class Profile
4/7
07:50 am
artl
Artelo Biosciences Regains Compliance with Nasdaq Listing Requirements
Medium
Report
Artelo Biosciences Regains Compliance with Nasdaq Listing Requirements
3/30
06:01 pm
artl
Artelo Biosciences Announces Closing of $11.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules [Yahoo! Finance]
High
Report
Artelo Biosciences Announces Closing of $11.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules [Yahoo! Finance]
3/30
05:07 pm
artl
Artelo Biosciences Announces Closing of $11.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules [TheStreet.com]
High
Report
Artelo Biosciences Announces Closing of $11.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules [TheStreet.com]
3/30
04:46 pm
artl
Artelo Biosciences Announces Closing of $11.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules
High
Report
Artelo Biosciences Announces Closing of $11.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules
3/30
06:18 am
artl
Artelo Biosciences (ARTL) had its "sell (e+)" rating reaffirmed by
Weiss Ratings.
Medium
Report
Artelo Biosciences (ARTL) had its "sell (e+)" rating reaffirmed by
Weiss Ratings.
3/27
10:40 am
artl
Artelo Biosciences Announces $11.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules
Medium
Report
Artelo Biosciences Announces $11.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules
3/25
04:05 pm
artl
Artelo Biosciences Expands ART27.13 Development as a Potential Companion Therapy to GLP-1 Treatments
High
Report
Artelo Biosciences Expands ART27.13 Development as a Potential Companion Therapy to GLP-1 Treatments
3/25
07:31 am
artl
Artelo Biosciences Expansion into $16.3B Glaucoma Market, Via Fully Funded Study, Highlights Multi-Platform Pipeline Strength
High
Report
Artelo Biosciences Expansion into $16.3B Glaucoma Market, Via Fully Funded Study, Highlights Multi-Platform Pipeline Strength
3/18
01:33 pm
artl
Artelo Biosciences Inc [CNN]
High
Report
Artelo Biosciences Inc [CNN]
3/18
08:13 am
artl
Artelo Announces Third-Party Fully Funded Clinical Study Agreement to Evaluate ART27.13 in Glaucoma Patients [Yahoo! Finance]
Medium
Report
Artelo Announces Third-Party Fully Funded Clinical Study Agreement to Evaluate ART27.13 in Glaucoma Patients [Yahoo! Finance]
3/18
08:07 am
artl
Vanderbilt Report: Artelo Biosciences Expands Into $16.3 Billion Glaucoma Market With Fully Funded Clinical Study
Medium
Report
Vanderbilt Report: Artelo Biosciences Expands Into $16.3 Billion Glaucoma Market With Fully Funded Clinical Study
3/18
07:41 am
artl
Artelo Announces Third-Party Fully Funded Clinical Study Agreement to Evaluate ART27.13 in Glaucoma Patients
High
Report
Artelo Announces Third-Party Fully Funded Clinical Study Agreement to Evaluate ART27.13 in Glaucoma Patients
3/8
06:42 am
artl
Artelo Biosciences announces 3-for-1 reverse stock split [Yahoo! Finance]
Low
Report
Artelo Biosciences announces 3-for-1 reverse stock split [Yahoo! Finance]
3/6
10:31 am
artl
Artelo biosciences announces reverse stock split [Seeking Alpha]
Medium
Report
Artelo biosciences announces reverse stock split [Seeking Alpha]
3/6
08:25 am
artl
Artelo Biosciences Announces Reverse Stock Split [Yahoo! Finance]
Neutral
Report
Artelo Biosciences Announces Reverse Stock Split [Yahoo! Finance]
3/6
08:00 am
artl
Artelo Biosciences Announces Reverse Stock Split
Medium
Report
Artelo Biosciences Announces Reverse Stock Split
2/24
08:00 am
artl
Artelo Biosciences Provides Business Update Highlighting Clinical Progress and Reports Fiscal 2025 Year-End Financial Results
Medium
Report
Artelo Biosciences Provides Business Update Highlighting Clinical Progress and Reports Fiscal 2025 Year-End Financial Results